Cibinetide

N/A

Report date: 2024/11/02 20:00:07
NME

Base Information

Drug NameCibinetide
Drug Alias Name西比奈肽cibinetidacibinetidumPyroglutamate helix B surface peptidepHBSP +[7] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsDiabetic macular oedemaDepressionGlucose Intolerance +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenNetherlandsUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAraim Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeiden University Medical CenterAraim Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsDiabetic macular oedemaDepressionGlucose Intolerance +[5] 

Other Information

ATC CodeN/A
Related LinksKEGG